Drug Takeback Solutions Foundation

990 • Fiscal year 2023 • EIN 85-1666391

Jan 01, 2023 to Dec 31, 2023

Organization Profile NONE

Winston Salem, NC

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

7.01x

Higher debt load relative to assets than 100% of similar nonprofits.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2023

1.58x

Higher debt load relative to revenue than 91% of similar nonprofits.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2023

-131%

Higher net margin than 3% of similar nonprofits.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2023

No value available

This filing does not contain officer compensation rows.

Source year 2023

596%

Faster asset growth than 99% of similar nonprofits.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2022 to 2023

149%

Faster revenue growth than 94% of similar nonprofits.

2023 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2022 to 2023

Balance Sheet

Liabilities / Assets100th percentile

Assets

$463,256

Up $396,687 (+596%) from 2022

Net Assets

Down

-$2,785,303

Down $2,682,775 (-2617%) from 2022

Liabilities

$3,248,559

Up $3,079,462 (+1821%) from 2022

Revenue And Expenses

Liabilities / Revenue91st percentile Net Margin3rd percentile

Revenue

$2,055,249

Up $1,228,556 (+149%) from 2022

Expenses

$4,738,024

Up $3,835,194 (+425%) from 2022

Net Income

Down

-$2,682,775

Down $2,606,638 (-3424%) from 2022

Historical Trend

Balance Sheet Trend

Asset Growth99th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

Highlighted filing

2023

Assets$463,256

Liabilities$3,248,559

Net Assets-$2,785,303

Open 2023 Filing

Operations Trend

Revenue Growth94th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

Highlighted filing

2023

Revenue$2,055,249

Expenses$4,738,024

Net Income-$2,682,775

Open 2023 Filing

Filing Detail Status

This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

View Latest Detailed Filing (2024)

Jump To

Filing Snapshot

Filing Period: Jan 1, 2023 to Dec 31, 2023

Mission and Program Overview

Mission

The foundation, an organization exempt from federal income tax under section 501(c)(3) of the internal revenue code of 1986, as amended (the "code"), carries on various charitable and educational programs and activities supporting its primary mission to represent persons that manufacture drugs (both prescription and nonprescription, branded and generic), herbal remedies, drug products, biologics, medical devices and any other similar products to plan and operate drug take-back programs and similar drug stewardship programs in u.s. States and jurisdictions that pass drug take-back or similar drug stewardship laws.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2023 • Form 990Summary only. Only limited summary data is available for this year.

Open filing

Assets: $463,256
Liabilities: $3,248,559
Net assets: -$2,785,303
Revenue: $2,055,249
Expenses: $4,738,024
Net income: -$2,682,775

	Balance Sheet			Operations
Year	Assets	Liabilities	Net Assets	Revenue	Expenses	Net Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.	$1.89	$6.27	$4.39	$3.08	$4.74	$1.65
2023Summary only. Only limited summary data is available for this year.	$0.46	$3.25	$2.79	$2.06	$4.74	$2.68
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.	$0.07	$0.17	$0.10	$0.83	$0.90	$0.08
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.	$0.01	$0.04	$0.03	$0.02	$0.05	$0.03
2020Facts available. Structured filing facts are available, but richer extracted sections are limited.	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00